View Clinical Trial (Medical Research Study)

Attention Shaping Procedures for Improving Psychosocial Skills Among Adults With Schizophrenia - NCT00391677-08852(Clinical Trial 153922)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Monmouth Junction
State:  
NJ
Zip Code: 08852
Conditions: Schizophrenia
Purpose: This study will evaluate the effectiveness of attention shaping procedures in improving attentiveness and learning abilities in people undergoing psychosocial skills training treatment for schizophrenia.
Study summary: Schizophrenia is a disabling mental disorder that can interfere with a person's ability to function both alone and in social situations. Various treatments have been effective in treating schizophrenia, including antipsychotic medications and cognitive therapy. Psychosocial skills training, a type of cognitive therapy, is often used to help people with schizophrenia cope with their condition and improve social functioning in day-to-day life. However, many individuals with schizophrenia experience difficulty paying attention, and this is a significant barrier to successful outcomes in psychosocial skills training interventions. Attention shaping procedures (ASP) is a behavioral intervention that helps individuals with impaired attention capacities to benefit from skills-based treatment. This study will evaluate the effectiveness of ASP in improving attentiveness and learning abilities in people undergoing psychosocial skills training treatment for schizophrenia. Participants in this 5-month, single-blind study will be randomly assigned to ASP plus basic conversation skills training (BCS), which is a social skills training group, or BCS alone. Training sessions for both groups will be held when participants attend regular hospital visits. During the first month, participants will complete two sessions of interviews, self-report scales, and social and cognitive functional assessments. Over the next 3 months, training sessions for both groups will occur twice a week for approximately 1 hour. ASP sessions will focus on setting goals and increasing the quality and duration of participants' attentiveness during psychosocial interventions. BCS will train participants in the following five skill areas: recognizing verbal and non-verbal cues; starting a friendly conversation; keeping conversation going; ending a conversation politely; and incorporating all of these skills together. During the last month, participants will attend two interview sessions lasting approximately 4 hours each. One follow-up session will occur 6 months after completing the intervention.
Criteria: Inclusion Criteria: - Diagnosis of schizophrenia, as confirmed by a diagnostic interview - Has experienced difficulty paying attention while in groups during a treatment program, as determined by program staff - Has experienced problems with social skills, as determined by program staff and study clinicians - Social skill deficits, as determined by study clinicians Exclusion Criteria: - Diagnosis of mental retardation (including borderline or mild mental retardation) - Diagnosis of autism, Asperger's syndrome, or another childhood disorder involving learning or relating to other people - History of a neurological disorder, including epilepsy, traumatic brain injury with loss of consciousness, coma, stroke, Parkinson's disease, etc. - Diagnosis of active substance abuse (history of a substance abuse disorder without a current substance abuse problem will not be a criterion for exclusion)
Study is available at: University Behavioral HealthCare
Monmouth Junction, NJ 08852
United States

Primary Contact:
Steven M. Silverstein, PhD
Email: silvers1@umdnj.edu
Phone: 732-235-5149

Secondary Contact:
Steven M. Silverstein, PhD
Email: silvers1@umdnj.edu
Phone: 732-235-5149
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 21, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.